[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Normal_2610 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1101151110033596416.png) Normal Guy [@Normal_2610](/creator/twitter/Normal_2610) on x 2014 followers
Created: 2025-07-16 15:45:58 UTC

Risks include heavy dependency on X molecules (71% revenue), patent expiry (2027-2039), geopolitical issues affecting Europe/US revenue (~60%), competition (WuXi, Lonza, Syngene), scaling challenges of new Unit III, high IPO valuation (70x earnings), and full Offer-for-Sale IPO (no new money raised for growth).

![](https://pbs.twimg.com/media/Gv_WWgtXwAAIndu.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945510225530028537/c:line.svg)

**Related Topics**
[money](/topic/money)
[ipo](/topic/ipo)
[$lonnsw](/topic/$lonnsw)

[Post Link](https://x.com/Normal_2610/status/1945510225530028537)